BRCA1 and breast carcinoma: In conclusion, the present meta-analysis indicated that the BACH1 919Ser polymorphism may decrease the risk of breast cancer among Caucasian populations, particularly in postmenopausal females with a family history of breast cancer and without BRCA1/2 mutations.